Samuel Bastos Serra Trinca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samuel Bastos Serra Trinca has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Amandine Dupuy
CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR1064, ITUN, Nantes, 44000, France
2 shared publications - Hoa Le Mai
CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR1064, ITUN, Nantes, 44000, France
2 shared publications Marie Cornic
UMR1236, Université Rennes, INSERM, Etablissement Français du Sang, Rennes, France
2 shared publications- Michel Cogné
UMR1236, Université Rennes, INSERM, Etablissement Français du Sang, Rennes, France
2 shared publications Karin Tarte
UMR1236, Université Rennes, INSERM, Etablissement Français du Sang, Rennes, France
1 shared publication- Karin Tarte
15Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche U127, Université Rennes, Etablissement Français du Sang Bretagne, LabEx IGO, Rennes, France
1 shared publication
Latest Publications
- Open Access
- 17 April 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 46, 102594
Granzyme B-expressing regulatory B cells share the same origin as conventional blood B cells
- 17 April 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 46, 102594
Open AccessGranzyme B-expressing regulatory B cells share the same origin as conventional blood B cells
- Open Access
- 9 March 2026
- Published by Elsevier in SSRN Electronic Journal
Granzyme B-expressing regulatory B cells share the same origin as conventional blood B cells
Regulatory B cells (Bregs) play a pivotal role in various dysimmune conditions. We have previously demonstrated that granzyme B-expressing (GZMB⁺) B cells are more numerous in patients with graft tolerance following kidney transplantation and that these cells display regulatory properties through GZMB. However, their ontogeny remains poorly understood. To address this gap, we analyzed the B cell receptor repertoire of GZMB⁺ Bregs and GZMB⁻ B cells sorted from healthy donors and drug-free tolerant kidney-graft recipients. This revealed that both subsets exhibited similar repertoire features in terms of diversity, V/J gene usage, CDR3 profile and somatic hypermutation pattern, suggesting a common origin and recent divergence. Furthermore, there was limited overlap between GZMB⁺ and GZMB⁻ clonotypes within individual donors. Taken together, these findings suggest that GZMB⁺ Bregs likely arise from the conventional mature B cell pool and represent a differentiation state shaped by environmental cues rather than constituting a distinct clonal lineage.
- 9 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessGranzyme B-expressing regulatory B cells share the same origin as conventional blood B cells
Regulatory B cells (Bregs) play a pivotal role in various dysimmune conditions. We have previously demonstrated that granzyme B-expressing (GZMB⁺) B cells are more numerous in patients with graft tolerance following kidney transplantation and that these cells display regulatory properties through GZMB. However, their ontogeny remains poorly understood. To address this gap, we analyzed the B cell receptor repertoire of GZMB⁺ Bregs and GZMB⁻ B cells sorted from healthy donors and drug-free tolerant kidney-graft recipients. This revealed that both subsets exhibited similar repertoire features in terms of diversity, V/J gene usage, CDR3 profile and somatic hypermutation pattern, suggesting a common origin and recent divergence. Furthermore, there was limited overlap between GZMB⁺ and GZMB⁻ clonotypes within individual donors. Taken together, these findings suggest that GZMB⁺ Bregs likely arise from the conventional mature B cell pool and represent a differentiation state shaped by environmental cues rather than constituting a distinct clonal lineage.